ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
bullish•Mint /
•24 Jul 2024 10:34•Broker

Keep a Close Watch on Flash Manufacturing and Services PMIs in July for the US and EU

Technically, the SET Index is expected to weaken, with the support at 1,292/1,286 points and the resistance at 1,309/1,317 points. In the short...

Logo
96 Views
Share
bearish•K Bank
•19 Jul 2024 10:22•Broker

Keep a Close Watch on Thai Banks' Earnings

Technically, the SET Index is expected to move sideways, with the support at 1,320/1,317 points and the resistance at 1,332/1,346 points. The...

Logo
88 Views
Share
bullish•Thaifoods Group
•21 May 2024 10:38•Broker

EU's Trade Balance and Discussion on Establishment of LTFs

Technically, the SET Index is expected to move sideways, with the resistance at 1,390/1,395 points and the support at 1,375/1,372 points (50-day...

Logo
91 Views
Share
bearish•SciSparc
•05 Apr 2024 10:53•Broker
Logo
82 Views
Share
bullish•SciSparc
•04 Apr 2024 11:03•Broker

Big Cap Tactical Picks

SPRC has been added to the portfolio on the back of its strong net profit prospects, underpinned mainly by the robust recovery of the market GRM...

Logo
82 Views
Share
x